Follow Us:
Monday, May 25, 2020

Deepak Patel

Profile

Upcoming payouts a possible trigger for Singh brothers feud
Thu, Sep 06, 2018

In February, Delhi HC upheld the Singapore arbitration tribunal’s decision to fine the brothers for around Rs 3,500 crore for “concealing and misrepresenting” facts.

Johnson and Johnson faulty hip implants: Health ministry asks states to form panels to determine compensation size
Wed, Sep 05, 2018

The expert panel, which submitted its report on February 19, recommended that the company should be made liable to pay at least Rs 20 lakh to each affected patient and that the reimbursement programme for revision surgeries continue until August 2025.

Shivinder moves NCLT against elder brother, ex-Religare CMD
Wed, Sep 05, 2018

The brothers used to be promoters of Fortis Healthcare, REL as well as Ranbaxy Laboratories. RHC Holding is an investment firm controlled by them.

District Mineral Foundations: Centre likely to authorise independent study
Tue, Sep 04, 2018

Centre has advised states that the money collected by DMFs should be used in just two or three schemes for proper utilisation of funds, The Indian Express had reported in May.

Delhi High Court suspends Centre’s Oxytocin ban till October
Sat, Sep 01, 2018

According to Centre, Oxytocin is misused by the farmers in growing abnormally large sized vegetables and by dairy owners to extract larger amounts of milk from cows and buffaloes.

Stray cases aside, Oxytocin misuse not rampant: Delhi High Court
Fri, Aug 31, 2018

A two-judge Bench of Justices S Ravindra Bhat and A K Chawla were hearing three petitions on Thursday against the proposed ban on Oxytocin production by private companies for domestic use. As per Centre’s notification, this ban would come in effect from September 1.

Maharashtra Druggists’ body to pharma firms: ‘Refrain from unethical practices to boost sales’
Thu, Aug 30, 2018

The letter dated August 27, states that “we have come to know from reliable market sources that your company’s MR/manager comes in the month-end to complete primary target” and then this employee is “adjusting” by paying from his incentives/salary, which is “highly objectionable and warrant your immediate attention”.

RHC Holding seeks about Rs 2,500 crore from Religare in damages
Thu, Aug 30, 2018

According to a tripartite agreement signed by RHC, REL and RCML on February 13: “RHC entities infused preference share capital to the tune of Rs 1,333.47 crore in RCML in various trances between 2011-12 and 2015-16.”

Why single out Oxytocin? Delhi High Court asks Centre
Thu, Aug 30, 2018

Oxytocin is administered to pregnant women to “prevent and treat” postpartum haemorrhage (PPH). PPH accounts for about 35 per cent of all maternal deaths, says the World Health Organization.

Johnson & Johnson’s faulty hip implants: Adverse report is out after patients asked for it
Wed, Aug 29, 2018

On Tuesday evening, the Central Drugs Standard Control Organisation (CDSCO), the national pharmaceutical and medical devices regulator, uploaded the report on its website. The report was submitted in February.

Green Clearances: Nearly a year later, list of issues ailing hydro units still in the works
Wed, Aug 29, 2018

As on August 10, over 11 months since that decision, no such list has been submitted.

Centre quotes just one scientific study to substantiate Oxytocin misuse
Sat, Aug 25, 2018

To substantiate the rampant misuse of Oxytocin, the Central government has quoted 14 news reports and website blogs and just one scientific study in its counter affidavit filed with the Delhi High Court on Thursday.

Top official sought CBI probe into hip implants sold by Indian arm of Johnson & Johnson: ‘Failure of govt’
Sat, Aug 25, 2018

But the Centre decided in July 2015 against such a probe on the grounds that “referring the case to CBI may not help the compensation claim” of patients.

Government permits Oxytocin sale through private chemists
Thu, Aug 23, 2018

Oxytocin’s import has already been banned by the Central government. From September 1, only Karnataka Antibiotics & Pharmaceuticals Limited (KAPL), a public sector entity, would be permitted to manufacture and distribute Oxytocin in India.

Fluoroquinolones drugs: Changes in labelling likely
Wed, Aug 22, 2018

On August 3, MoS for health and family welfare told Lok Sabha that “...DCGI is examining the issue in consultation with subject expert committee of CDSCO”.

Oxytocin ban from September 1: Centre pleads for more time to submit counter affidavit
Mon, Aug 20, 2018

While this ban would come into effect from September 1, Centre is yet to submit its counter affidavit. Last Thursday, Centre pleaded for more time to submit it.

CIL list a work in progress, six months after power ministry order
Mon, Aug 13, 2018

Number of thermal plants running at sub-optimum levels for past 11 months

Rajasthan drug regulator: Brands of 4 firms substandard
Fri, Aug 10, 2018

Companies say samples tested are ‘counterfeit’ or ‘spurious’

India-Australia CECA talks under ‘slow period’ now
Thu, Aug 09, 2018

While releasing the report titled ‘An India Economic Strategy to 2035’, Sidhu said: “We are going through that process right now, the CECA, and it is never a steady pace."

Stressed assets: ‘MSMEs worse-placed than power projects’
Thu, Aug 09, 2018

On February 12 this year, the RBI had issued a ‘Revised Framework for Resolution of Stressed Assets’ that stipulates that default of even a single day in payment of interest or principal amount would trigger a formulation of resolution plan by the committee of creditors.

Advertisement
Advertisement
Advertisement
Advertisement